Sumitomo Chemical logo

Sumitomo Chemical

SUMICHEM NSE

Key Fundamentals

SmallcapPesticides & AgrochemicalsChemicals
Market Cap
₹23,360 Cr
Volatility
Moderate
P/E Ratio
41
EBITDA
₹818 Cr
Return on Equity
16%
Debt to Equity
0.02
Book Value
₹67.91
EPS
₹8.71
52W High
₹617.45
52W Low
₹362.6

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

2
  • Company is almost debt free.
  • Company has been maintaining a healthy dividend payout of 34.5%

Weaknesses

2
  • Stock is trading at 7.03 times its book value
  • The company has delivered a poor sales growth of 3.81% over past five years.

Growth Rate

Revenue Growth
3.56% higher than 3Y
Net Income Growth
7.23% higher than 3Y
Cash Flow Change
-1.33% higher than 3Y
ROE
-8.2% lower than 3Y
ROCE
-8.3% lower than 3Y
EBITDA Margin (Avg.)
4.95% lower than 3Y

AI Analysis — Bull vs Bear

Anthropic anthropic claude-opus-4.6 2d ago
AI opinion · based on fundamentals
Risk medium

Sumitomo Chemical India Ltd is a nearly debt-free agrochemical company with a market cap of ₹23,360 Cr trading at a PE of 41.5x and PB of 7.09x. While the company has delivered strong long-term profit compounding of 24% over 10 years, recent sales have contracted by -3% on a TTM basis and the stock has declined 16% over the past year.

Bull Case 7
  • The company is almost debt-free, providing strong balance sheet resilience and financial flexibility in a cyclical agrochemical industry.
  • Long-term compounded profit growth stands at an impressive 24% CAGR over 10 years, indicating sustained earnings power.
  • 10-year compounded sales CAGR of 16% demonstrates a solid long-term revenue expansion track record.
  • Return on equity has remained consistently healthy at 17-20% across 3, 5, and 10-year periods, with the last year at 18%, reflecting efficient capital deployment.
  • The company maintains a healthy dividend payout ratio of 34.5%, returning meaningful capital to shareholders despite being in a growth phase.
  • 5-year compounded profit growth of 10% shows the company has continued to grow earnings even through recent agrochemical industry headwinds.
  • Current dividend yield of 0.27% provides a modest income floor, supported by the debt-free balance sheet that makes payouts sustainable.
Bear Case 8
  • TTM sales have contracted by -3%, and the 3-year compounded sales CAGR is also -3%, signaling a meaningful and sustained revenue slowdown.
  • The stock trades at 7.09x book value, a steep premium that leaves limited margin of safety if growth does not re-accelerate.
  • At a PE of 41.5x, the valuation is elevated relative to the current earnings trajectory, especially given the -3% TTM sales decline.
  • 5-year sales CAGR is only 3.81%, indicating that outside of the longer historical period, recent top-line performance has been weak.
  • The stock has delivered a negative 1-year return of -16%, underperforming and reflecting market skepticism about near-term prospects.
  • 3-year and 5-year stock price CAGRs of just 4% and 3% respectively suggest the market has largely de-rated the stock over the medium term.
  • TTM profit growth of only 3% is modest given the 41.5x PE multiple, implying the current valuation requires a significant earnings recovery to be justified.
  • The wide gap between the 10-year sales CAGR of 16% and the recent 3-year CAGR of -3% points to a structural deceleration in growth momentum.

This is AI-generated analysis, not financial advice. Do your own due diligence.

AI News Digest

Anthropic anthropic claude-opus-4.6 2h ago
Neutral 1
  • Investor meet scheduled Sep 3 Aug 25

    Sumitomo Chemical India will host institutional investors and analysts on September 3, 2026 in Mumbai, organized by Elara Capital. Meetings will cover publicly available information only.

TL;DR: Limited recent news flow for Sumitomo Chemical India with only a routine investor meeting scheduled for Sep 3. No material headwinds or positive catalysts in the current news cycle. The upcoming analyst meet could provide more color on business outlook, but no new information is expected beyond what is already public.

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
724
903
540
664
832
971
622
665
1,048
914
552
671
1,054
Expenses
643
715
474
526
670
729
521
548
828
697
456
539
819
Operating Profit
81
188
66
139
162
242
101
117
220
217
96
133
235
OPM %
11%
21%
12%
21%
19%
25%
16%
18%
21%
24%
17%
20%
22%
Other Income
18
25
27
27
26
31
31
31
39
39
22
32
74
Interest
1
1
1
1
1
1
1
1
1
2
2
2
2
Depreciation
14
16
16
16
14
15
18
16
15
16
16
16
16
PBT
83
196
76
149
173
257
113
132
242
238
100
147
291
Tax %
26%
27%
27%
26%
26%
26%
25%
25%
26%
25%
25%
25%
26%
Net Profit
62
144
55
109
128
191
84
98
180
178
75
111
217
EPS in Rs
1.24
2.88
1.1
2.19
2.57
3.82
1.69
1.97
3.6
3.56
1.5
2.22
4.34
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
671
724
799
1,911
2,223
2,423
2,643
3,060
3,511
2,833
3,090
3,186
3,192
Expenses
614
635
698
1,691
1,932
2,088
2,155
2,458
2,843
2,358
2,467
2,520
2,511
Operating Profit
57
89
101
219
291
335
488
603
668
474
623
666
680
OPM %
8%
12%
13%
11%
13%
14%
18%
20%
19%
17%
20%
21%
21%
Other Income
8
26
10
31
0
-20
19
36
45
96
119
131
166
Interest
1
1
1
5
5
7
7
8
6
5
6
7
7
Depreciation
6
7
7
24
28
41
47
45
52
61
63
63
64
PBT
58
107
103
221
258
267
453
586
655
503
674
727
776
Tax %
40%
40%
40%
34%
35%
23%
24%
26%
23%
27%
26%
25%
—
Net Profit
35
65
62
145
167
206
345
434
503
370
502
543
580
EPS in Rs
—
—
—
—
—
4.12
6.92
8.69
10.09
7.41
10.06
10.88
11.62
Div. Payout %
0%
0%
0%
0%
38%
18%
12%
12%
12%
80%
12%
12%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
233
233
275
275
275
499
499
499
499
499
499
499
Reserves
-2
63
360
665
761
710
1,029
1,425
1,881
1,941
2,397
2,885
Borrowings
0
0
0
10
20
36
33
38
34
25
45
53
Other Liabilities
234
280
288
695
791
848
1,097
1,047
955
822
988
997
Total Liabilities
466
576
922
1,644
1,846
2,093
2,658
3,009
3,368
3,287
3,930
4,434
Fixed Assets
51
52
53
267
279
319
309
390
430
489
482
499
CWIP
0
1
7
9
8
10
14
35
71
23
28
20
Investments
0
0
277
2
1
87
291
357
239
425
601
1,226
Other Assets
415
523
585
1,367
1,558
1,676
2,043
2,227
2,628
2,351
2,819
2,690
Total Assets
466
576
922
1,644
1,846
2,093
2,658
3,009
3,368
3,287
3,930
4,434
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
4
52
-21
49
75
222
424
223
389
756
458
443
Investing
-8
-5
-289
-40
-35
-118
-282
-281
-327
-426
-405
-329
Financing
0
0
276
7
-65
-61
-47
-63
-73
-331
-65
-81
Net Cash Flow
-4
47
-34
16
-26
43
95
-120
-10
-1
-11
33
Free Cash Flow
-6
44
-310
6
36
184
382
111
270
695
431
404
CFO/OP
44
102
14
60
56
90
109
61
83
187
100
91
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
83
92
101
105
110
128
117
101
98
91
90
81
Inventory Days
135
169
191
202
193
133
185
198
157
135
154
166
Days Payable
109
132
115
176
136
112
145
110
87
96
107
86
Cash Conversion Cycle
109
130
177
131
167
150
157
189
168
131
136
161
Working Capital Days
69
79
113
113
116
109
95
127
136
173
183
155
ROCE %
27%
41%
22%
29%
27%
26%
33%
34%
30%
21%
25%
23%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Sumitomo Chemical insights

52 extracted metrics + investor summaries across FY15–FY27.

Log in — free

Shareholding Pattern

FIIs3.02%Promot.75.00%Others3.53%Public9.12%DIIs9.33%As ofJun 2026

Documents

Frequently Asked Questions about Sumitomo Chemical

What does Sumitomo Chemical India Ltd do?
Sumitomo Chemical India Ltd. (SCIL) is one of the leading players in the industry which has a balanced portfolio of technical as well as formulation products along with backward integration for some products. The Company is known for domestic marketing of proprietary products of its Japanese pare...
Where is Sumitomo Chemical India Ltd (SUMICHEM) listed?
Sumitomo Chemical India Ltd trades as SUMICHEM on the NSE and under code 542920 on the BSE.
Which sector does Sumitomo Chemical India Ltd belong to?
Sumitomo Chemical India Ltd is classified under the Commodities sector, in the Fertilizers & Agrochemicals industry.
What is the market capitalisation of Sumitomo Chemical India Ltd?
Sumitomo Chemical India Ltd has a market capitalisation of ₹23,360 Cr, which places it in the Large Cap band.
What is the PE ratio of Sumitomo Chemical India Ltd?
Sumitomo Chemical India Ltd trades at a PE ratio of 41.00, on earnings per share of ₹8.71, against a book value of ₹67.91 per share.
What is the 52-week high and low of Sumitomo Chemical India Ltd?
Over the last 52 weeks Sumitomo Chemical India Ltd has traded between ₹362.6 and ₹617.45.
Does Sumitomo Chemical India Ltd pay dividends?
Sumitomo Chemical India Ltd has a dividend yield of 0.27%.
What is the Return on Equity (ROE) of Sumitomo Chemical India Ltd?
Sumitomo Chemical India Ltd reported a return on equity of 16.00%. Its debt-to-equity ratio is 0.02.

Company Information

Sumitomo Chemical India Ltd. (SCIL) is one of the leading players in the industry which has a balanced portfolio of technical as well as formulation products along with backward integration for some products. The Company is known for domestic marketing of proprietary products of its Japanese parent -Sumitomo Chemical Company Limited in agrochemicals, animal nutrition, and environmental health business segments. With the integration of Excel Crop Care Limited, the Company now has a strong portfolio of generics in addition to specialty products and a strong combined marketing network. With this integration, the Company has moved up several notches in the pecking order of the Indian crop protection industry. SCIL has also marked its presence in Africa and several other geographies of the world.[1] [2]

Website sumichem.co.in
CEO Mr. Chetan Shantilal Shah
Employees 1,646
Listed 2020-01-27
Face Value ₹ 10
Issued Size 49,91,45,736

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/SUMICHEM.md for Sumitomo Chemical India Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Commodities → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List